SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001420720-23-000065
Filing Date
2023-11-28
Accepted
2023-11-28 08:36:43
Documents
16
Period of Report
2023-11-27
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20231127x8k.htm   iXBRL 8-K 91636
2 EX-3.1 ibio-20231127xex3d1.htm EX-3.1 14450
3 EX-10.1 ibio-20231127xex10d1.htm EX-10.1 94020
4 EX-99.1 ibio-20231127xex99d1.htm EX-99.1 11406
  Complete submission text file 0001420720-23-000065.txt   374337

Data Files

Seq Description Document Type Size
5 EX-101.SCH ibio-20231127.xsd EX-101.SCH 4162
6 EX-101.DEF ibio-20231127_def.xml EX-101.DEF 3261
7 EX-101.LAB ibio-20231127_lab.xml EX-101.LAB 14525
8 EX-101.PRE ibio-20231127_pre.xml EX-101.PRE 10783
10 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20231127x8k_htm.xml XML 4857
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 231441989
SIC: 2834 Pharmaceutical Preparations